The pathogenetic bases of sarcopenia
- PMID: 26136791
- PMCID: PMC4469221
- DOI: 10.11138/ccmbm/2015.12.1.022
The pathogenetic bases of sarcopenia
Abstract
Aging is accompanied by involuntary loss of skeletal muscle mass, strength and function, called sarcopenia. The mechanisms underlying the development of sarcopenia are not completely understood and most likely multi-factorial, but significant progress has been made over the past few years to identify some of the major contributors. Besides life style-related factors, as diet and physical activity, sarcopenia seems to be also determined by hormonal dysregulation, chronic inflammatory status, ectopic adipose tissue accumulation, neurological and vascular changes associated with aging. The present mini-review focused on the basic factors that primarily impact muscle homeostasis in older subjects. A better understanding of cellular mechanism leading to sarcopenia is required to establish evidence-based intervention in order to prevent onset of symptoms associated with sarcopenia and to extend the time free from disability in older adults.
Keywords: aging; chronic inflammation; muscle lipotoxicity; sarcopenia.
Figures
References
-
- Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 years. J Appl Physiol. 2000;89:81–88. - PubMed
-
- Visser M, Schaap LA. Consequences of sarcopenia. Clin Geriatric Med. 2011;27(3):387–399. - PubMed
-
- Van Kan GA. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13(8):708–712. - PubMed
-
- Bunout D, de la Maza MP, Barrera G, et al. Association between sarcopenia and mortality in healthy older people. Australian J Ageing. 2011;30(2):89–92. - PubMed
-
- OECD Factbook. Econimic, Environmental and Social Statistics. 2009. http://dx.doi.org/10.1787/factbook-2009-en. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous